Altered hip muscle forces during gait in people with patellofemoral osteoarthritis  by Crossley, K.M. et al.
Osteoarthritis and Cartilage 20 (2012) 1243e1249Altered hip muscle forces during gait in people with patellofemoral osteoarthritis
K.M. Crossley yz*, T.W. Dorn y, H. Ozturk y, J. van den Noort yx, A.G. Schache y, M.G. Pandy y
yDepartment of Mechanical Engineering, University of Melbourne, Parkville, Victoria 3010, Australia
z School of Health and Rehabilitation Sciences, University of Queensland, Brisbane, Queensland 4072, Australia
xDepartment of Rehabilitation Medicine, Research Institute MOVE, VU University Medical Center, Amsterdam, The Netherlandsa r t i c l e i n f o
Article history:
Received 22 November 2011
Accepted 18 July 2012
Keywords:
Patella
Knee pain
Arthritis
Joint biomechanics
Walking
Musculoskeletal model* Address correspondence and reprint requests t
Health and Rehabilitation Sciences, University of
Australia. Tel: 61-7-3365-2275; Fax: 61-7-3346-8789
E-mail address: k.crossley@uq.edu.au (K.M. Crossl
1063-4584/$ e see front matter  2012 Osteoarthriti
http://dx.doi.org/10.1016/j.joca.2012.07.011s u m m a r y
Objectives: The study aimed to (1) assess whether higher vasti (VASTI), gluteus medius (GMED), gluteus
maximus (GMAX) and gluteus minimus (GMIN) forces are associated with participant characteristics
(lower age, male gender) and clinical characteristics (lower radiographic disease severity, lower
symptom severity and higher walking speed); and (2) determine whether hip and knee muscle forces are
lower in people with patellofemoral joint (PFJ) osteoarthritis (OA) compared to those without PFJ OA.
Design: Sixty participants with PFJ OA and 18 (asymptomatic, no radiographic OA) controls 40 years
were recruited from the community or via referrals. A three-dimensional musculoskeletal model was
used in conjunction with optimisation theory to calculate lower-limb muscle forces during walking.
Associations of peak muscle forces with participant and clinical characteristics were conducted using
Pearson’s r or independent t-tests and between-group comparisons of mean peak muscle forces per-
formed with walking speed as a covariate.
Results: Peak muscle forces were not signiﬁcantly associated with participant, symptomatic or
radiographic-speciﬁc characteristics. Faster walking speed was associated with higher VASTI muscle
force in the PFJ OA (r ¼ 0.495; P < 0.001) and control groups (r ¼ 0.727; P ¼ 0.001) and higher GMAX
muscle force (r ¼ 0.593; P ¼ 0.009) in the control group only. Individuals with PFJ OA (N ¼ 60) walked
with lower GMED and GMIN muscle forces than controls (N ¼ 18): GMED, mean difference 0.15 [95%
conﬁdence interval (CI): 0.01 to 0.29] body weight (BW); GMIN, 0.03 [0.01 to 0.06] BW. No between-
group differences were observed in VASTI or GMAX muscle force: VASTI, 0.10 [0.11 to 0.31] BW;
GMAX, 0.01 [0.11 to 0.09] BW.
Conclusion: Individuals with PFJ OA ambulate with lower peak hip abductor muscle forces than their
healthy counterparts.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Patellofemoral joint (PFJ) osteoarthritis (OA) is a common
disease, affecting approximately two thirds of those with symp-
tomatic knee OA1,2. Importantly, the PFJ is also a major source of
knee pain and reduced physical function2, exceeding the contri-
bution from the tibiofemoral joint3,4. Despite its prevalence and
associated morbidity, little is known about the features of people
with PFJ OA. The biomechanics of the PFJ are distinct from the
tibiofemoral joint and hence, interventions that have been
designed to reduce pain and improve function in those with
tibiofemoral disease may be inappropriate for those witho: K.M. Crossley, School of
Queensland, Brisbane 4072,
.
ey).
s Research Society International. Ppredominant PFJ OA. Given the heterogeneity of aetiology, symp-
tomatic presentation and natural history of knee OA, it appears as
though optimal interventions should consider targeting the salient
features associated with the compartmental involvement5. The
local PFJ biomechanics, and in particular alignment of the patella
within the femoral trochlea, is associated with PFJ OA6,7 and its
progression8. Consequently, the few trials that evaluated targeted
interventions for PFJ OA focused on addressing patellar alignment
via passive techniques such as taping6,9 and bracing10. Such treat-
ments resulted in positive immediate effects, but limited longer-
term effects. It is possible that individuals exhibit more global
impairments (e.g., thigh and hip muscle dysfunction) that should
also be addressed in targeted interventions.
While there is a dearth of information on thigh and hip muscle
dysfunction in PFJ OA, similarities in pain characteristics and the
likely relationship between PFJ pain syndrome and incident PFJ OA
imply that analogies may be drawn from the greater body of
knowledge in PFJ pain syndrome. Impairments in hip muscleublished by Elsevier Ltd. All rights reserved.
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are features of individuals with PFJ pain syndrome11. Furthermore,
quadriceps weakness, measured via dynamometry, has been
identiﬁed as a feature of PFJ OA12 and is associatedwith progression
of OA in the PFJ13. The PFJ is intimately related to quadriceps
function and consequently, individuals exhibiting pain arising from
the PFJ may modify their walking behaviour in order to reduce
quadriceps force14. However, it is not known whether individuals
with PFJ OA ambulate with lower quadriceps and hip muscle forces
than their healthy counterparts.
Biomechanical evaluations of peoplewith PFJ pain syndrome are
frequently performed to identify impairments in gait. While many
studies have calculated net joint torques and powers to evaluate
biomechanical load, such measures do not provide quantitative
information about the function of individual muscles. Computa-
tional musculoskeletal modelling15 may be used to estimate muscle
forces during activities such as gait. Therefore, the aims of this
study were to (1) assess whether higher vasti (VASTI), gluteus
medius (GMED), gluteus maximus (GMAX) and gluteus minimus
(GMIN) forces are associated with participant characteristics (lower
age, male gender) and clinical characteristics (lower radiographic
disease severity, lower symptom severity and higher walking
speed); and (2) determine whether hip and knee muscle forces are
lower in people with PFJ OA compared to those without PFJ OA.
Materials and methods
Participants
Sixty people with symptomatic PFJ OA and 18 controls (no knee
pain and no radiographic OA) participated in this study. Peoplewith
predominant lateral PFJ OA were a subgroup of a larger cohort
recruited for a randomised controlled trial16 from advertisements
in the community and via medical and health practitioners’ refer-
rals. Inclusion criteria included: (1) aged at least 40 years; (2)
anterior- or retro-patellar knee pain severity 4 on an 11 point
numerical pain scale during at least two activities that load the PFJ
(e.g., stair ambulation, squatting and/or rising from sitting); (3)
pain during these activities present on most days during the past
month; and (4) Kellgren and Lawrence (K/L) grading of the lateral
PFJ 217 from skyline views18 and overall K/L grading (for the
tibiofemoral joint) 2 from postero-anterior views. The control
participants were also recruited from the community via adver-
tisements placed in local newspapers and posters. They had no
knee or other lower-limb complaints, were physically active and
had no radiographic OA (K/L grade 1 in all compartments).
Exclusion criteria included: (1) concomitant pain from other joints
affecting lower-limb function; (2) recent knee injections (prior 3
months); (3) body mass index (BMI) 35 kg m2; (4) knee or hip
arthroplasty or osteotomy; (5) physical inability to undertake
testing procedures; (6) neurological or other medical conditions;
and (7) inability to understand written and spoken English.
Participants underwent telephone and physical screening by
a single researcher (JL) prior to radiographs. Approval was granted
from the University of Melbourne Human Research Ethics
Committee, and all participants provided written informed
consent. Information on age and gender was collected from the
participants and BMI calculated from weight and height
measurements.
Radiographic disease severity
Radiographic severity of tibiofemoral joint OA was assessed
from a semi-ﬂexed, postero-anterior weight-bearing short ﬁlm
radiograph with the feet externally rotated by 10 using the K/Lgrading system17. Radiographic severity of PFJ OA was assessed
fromweight-bearing skyline radiographs, with the knee positioned
at 30e40 knee ﬂexion19, using the K/L grades applied to the PFJ
joint18. All grading was performed by two investigators (KMC and
RSH), with inter-rater reliability (k) for grading tibiofemoral joint
and PFJ radiographic OA on a subset of 39 participants ranging from
0.745 to 0.843.
Knee OA symptoms
The Knee Injury and Osteoarthritis Outcome Score (KOOS) was
used to assess patient reported outcomes20. The KOOS has ﬁve
subscales: pain, symptoms, function in activities of daily living
(ADL), function in sport and recreation (sport/rec), and knee-
related quality of life (QoL). Each of the ﬁve subscales addresses
symptoms over the previous week, and a normalised score (100
represents no symptoms and 0 represents maximum symptoms) is
calculated for each subscale from the original Likert responses. The
KOOS is reliable20 and has face validity for people with PFJ OA
symptoms. Thus, in the absence of any PFJ OA-speciﬁc outcome
measures, the KOOS was deemed to be appropriate for this study.
Calculation of muscle forces
A musculoskeletal computer model, implemented in Open-
Sim21, was used to calculate lower-limb muscle forces. Estimates of
lower-limb muscle forces for walking obtained using this model
have been evaluated previously22,23. The skeleton was represented
as an 8-segment, 21-degree-of-freedom linkage [Fig. 1(A)]. The
head, arms, and torso were modelled as a single rigid body, which
articulated with the pelvis via a ball-and-socket back joint. Each hip
was modelled as a ball-and-socket joint, and each knee as a modi-
ﬁed one-degree-of-freedom planar joint. Each talo-crural joint,
subtalar joint and metatarsophalangeal joint was modelled as
a hinge. The lower limbs and trunk were actuated by 92 muscle-
tendon units, each represented as a line segment joining an
origin point on the proximal segment to an insertion point on the
distal segment. The paths of muscles that wrapped over underlying
structures were modelled using via points21. Each muscle-tendon
unit was modelled as a three-element Hill-type muscle in series
with an elastic tendon24 [Fig. 1(B)]. For each participant, body-
segment inertial properties and muscle-tendon properties were
scaled from a generic adult model21 using body mass and segment
dimensions as scaling factors, respectively.
Experimental gait data were collected in the Biomotion Labo-
ratory, Department of Mechanical Engineering, University of Mel-
bourne, Australia. Three force plates embedded in the ﬂoor of the
laboratory were used to record ground reaction forces under both
legs at a sampling frequency of 1080 Hz (Advanced Mechanical
Technology Inc., Watertown, MA, USA). All ground reaction force
data were low-pass ﬁltered using a fourth-order Butterworth ﬁlter
with a cut-off frequency of 60 Hz. Kinematic data were recorded
using a video-based, motion capture system (Vicon, OxfordMetrics,
Oxford, UK) with nine cameras sampling at a frequency of 120 Hz.
Reﬂective markers were attached at speciﬁc locations on the
patient’s trunk, pelvis, both upper limbs and both lower limbs;
speciﬁcally at the C7 spinous process, acromioclavicular joint,
lateral elbow epicondyle, dorsal aspect of the wrist, anterior
superior iliac spine, mid-point between posterior superior iliac
spines, anterior mid and distal thigh, lateral mid and distal thigh,
lateral femoral epicondyle, proximal and distal anteromedial shank,
mid lateral shank, heel, lateral malleolus, lateral and medial mid-
foot, medial aspect of ﬁrst metatarsal-phalangeal joint, lateral
aspect of ﬁfth metatarsal-phalangeal joint, and dorsal aspect of ﬁrst
toe. Muscle electromyographic (EMG) datawere collected to enable
Fig. 1. Three-dimensional musculoskeletal model used in the present study. (A) The skeleton was modelled as a multi-body linkage comprised of 21 degrees of freedom, and was
actuated by 92 muscle-tendon units. (B) Each muscle-tendon actuator was represented as a Hill-type muscle (active and passive) in series with an elastic tendon. (C) The active
force, FM, developed by muscle was governed by its forceelengthevelocity surface, deﬁned by the muscle’s length, LM, and velocity of contraction, VM.
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estimates and muscle activations during walking. The EMG data
were recorded using pairs of Ag/AgCl surface electrodes (Motion
Laboratory Systems, Baton Rouge, LA, USA) mounted on the skin
over the GMAX, GMED, medial and lateral vasti, hamstrings, rectus
femoris (RF), gastrocnemius (GAS) and soleus (SOL). EMG datawere
sampled at 1080 Hz. The raw EMG signal was full-wave rectiﬁed
and a TeagereKaiser Energy (TKE) ﬁlter was then applied to the
rectiﬁed EMG signal to improve the onset and offset detection25.
Cross-talk was minimised by following published recommenda-
tions regarding the placement of surface electrodes26.
An initial static trial was performed with the participant
standing in a neutral pose and additional markers placed on the left
and right medial femoral epicondyles and medial malleoli.
Following the static trial, participants performed three gait trials at
a self-selected speed on a 10 m level walkway. Each participant’s
walking speed was calculated from the kinematic data by
measuring the average horizontal velocity of a marker mounted on
the posterior aspect of the pelvis.
A single representative gait trial for each participant was chosen
for analysis, and all analyses were performed in OpenSim21. An
inversekinematicsproblemwas solved todetermine themodel joint
angles that best matched the marker data obtained from the gait
analysis experiment27. The net joint torques were calculated using
a traditional inverse-dynamics approach28. A static optimisation
problem was then solved to decompose the joint torques intoindividualmuscle forces byminimising the sumof the squaresof the
muscle activations29,30. The optimisation solution was constrained
to the forceelengthevelocity surface of each muscle30 [Fig. 1(C)].
The lower-limb muscle forces of interest were: (1) GMAX; (2)
GMED; (3) GMIN; and VASTI (vastus lateralis, intermedius and
medialis combined). For each muscle group, peak force during the
stance phase was identiﬁed and then normalised to the partici-
pant’s body weight (BW).
Statistical analysis
All analyses were performed using the Statistical Package for the
Social Sciences (PASW Statistics 18, SPSS Inc., Chicago, IL) with an
alpha level of 0.05. Between-group differences in participant and
clinical characteristics were assessed using Student’s t-tests or chi
square tests, as appropriate. The associations between mean peak
muscle forces with participant and clinical characteristics were
mostly conducted using Pearson’s r correlation co-efﬁcient. For the
radiographic disease severity (ordinal data), the associations were
calculated with the Spearman’s rho correlation co-efﬁcients, while
independent t-test were used for gender. Between-group differ-
ences in mean peak muscle forces were analysed with walking
speed as a covariate using an Analysis of Covariance (ANCOVA). The
sample size (60 PFJ OA patients and 18 controls) provides >90%
power to detect a between-group difference in muscle force of 10%,
with a standard deviation (SD) of 10%.
Table II
Radiographic disease severity for the patellofemoral OA group (N ¼ 60)
Grade 0
N (%)
Grade 1
N (%)
Grade 2
N (%)
Grade 3
N (%)
Grade 4
N (%)
Tibiofemoral (K/L) 14 (23%) 18 (30%) 28 (47%) 0 0
Lateral patellofemoral (K/L)* 0 0 39 (65%) 11 (18%) 10 (17%)
K/L Kellgren and Lawrence scale17: 0 ¼ no OA; 4 ¼ severe OA.
* K/L Kellgren and Lawrence scale adapted for PFJ18.
Table III
Univariate associations between normalised peak muscle forces, participant and
clinical characteristics
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There were no statistically signiﬁcant differences for age,
height or gender between the PFJ OA group (N ¼ 60) and the
control group (N ¼ 18) (Table I). Those with PFJ OA were heavier
than the control individuals, with a greater BMI. In line with our
eligibility criteria, the most prevalent radiographic grade
(Table II) was K/L grade 2 in the lateral PFJ and in the tibiofe-
moral joint.
Self-selected walking speed was not different between the PFJ
OA group and the control group [mean difference (95% conﬁdence
intervale CI): 0.03 (0.04 to 0.11)] (Table I). However in the control
group, walking speed was signiﬁcantly correlated with VASTI
(r¼ 0.727; P¼ 0.001) and GMAX (r¼ 0.593; P¼ 0.009) peak forces,
but age was not statistically signiﬁcantly correlated with peak
muscle forces (Table III). In the PFJ OA group, walking speed was
signiﬁcantly correlated with VASTI peak force (r ¼ 0.495;
P < 0.001), but age did not statistically signiﬁcantly correlate with
peak muscle forces (Table III). There was no signiﬁcant effect of
gender on VASTI [0.12: (0.11 to 0.34)], GMAX [0.03: (0.12 to
0.06)], GMED [0.05: (0.18 to 0.08)] or GMIN [0.01: (0.03 to
0.02)] peak muscle force. Radiographic disease severity in the
tibiofemoral joint and lateral PFJ was not statistically signiﬁcantly
correlated with peak muscle forces in the PFJ OA group (Table III).
Additionally, no statistically signiﬁcant correlations were observed
between any subscale of the KOOS and peakmuscle forces in the PFJ
OA group (Table III).
There were differences in the peak muscle forces for GMED and
GMIN between the PFJ OA group and control group (Table IV and
Fig. 2). Individuals with PFJ OAwalked with lower GMED [0.15 (95%
CI: 0.01 to 0.29) BW]; and GMIN [0.03 (0.01 to 0.06) BW] muscle
forces than controls. No between-group differences were observed
in VASTI or GMAX muscle force: VASTI, 0.10 [0.11 to 0.31] BW;
GMAX, 0.01 [0.11 to 0.09] BW. Ensemble averages across the
stance phase of gait for normalised muscle forces are presented in
Fig. 2. Model predictions of muscle forces were in temporal
agreement with measured EMG activity (Supplementary Fig. 1),
providing a qualitative evaluation of the modelling approach used
in this study.Table I
Participant and clinical characteristics: patellofemoral OA and control groups
Pain-free
controly
N ¼ 18
Patellofemoral
OAy
N ¼ 60
Mean difference
[95% CI]
P value
Age (yrs) 53 (7) 58 (10) 4 [0.8 to 10] 0.096
Height (m) 1.65 (0.08) 1.69 (0.09) 0.03 [0.06
to 0.08]
0.186
Weight (kg) 66 (12) 78 (13) 12 [5e19] 0.001*
BMI (kg m2) 24.1 (3.4) 27.5 (3.7) 3.3 [1.4e5.3] 0.001*
Gender (n(%)) 14 Female
(78%)
39 Female (65%) e 0.236z
KOOS-pain e 63 (15) e e
KOOS-symptoms e 61 (16) e e
KOOS-ADL e 70 (16) e e
KOOS-sport/rec e 41 (22) e e
KOOS-QoL e 12 (16) e e
Walking speed
(m s1)
1.34 (0.13) 1.37 (0.17) 0.03 [0.04
to 0.11]
0.369
*Denotes statistically signiﬁcant, P < 0.05.
KOOS20 (100 ¼ no symptomse0 ¼ maximum symptoms).
KOOS-pain ¼ pain subscale of the KOOS.
KOOS-symptoms ¼ symptoms subscale of the KOOS.
KOOS-ADL ¼ ADL subscale of the KOOS.
KOOS-sport/rec ¼ sport and recreation subscale of the KOOS.
KOOS-QoL ¼ knee-related QoL subscale of the KOOS.
y All values are mean (SD) unless indicated.
z c2.Discussion
Awareness of the importance of the PFJ in the clinical picture of
knee OA is increasing due to its prevalence and contribution to knee
OA symptoms. Knowledge of impairments associated with this
subgroup of people with knee OA will advance our understanding
of this chronic disease. We found that people with PFJ OAwalk with
reduced hip abductor muscle forces, compared with pain-free,
aged-matched controls. Speciﬁcally, peak GMED and GMIN
muscle forces were approximately 11% lower than pain-free indi-
viduals. The variability in GMAX, GMED, GMIN and VASTI peak
muscle forces was not related to radiographic disease severity, knee
OA symptom severity or other participant characteristics.
To our knowledge, this is the ﬁrst study to estimate lower-limb
muscle forces in a cohort of people with PFJ OA. Our calculated peak
VASTI muscle force was higher [1.16 (95% CI: 1.06 to 1.26) BW] than
those reported for a single total knee patient walking with an
instrumented knee (0.73 BW)22. The temporal patterns of lower-
limb muscle forces were similar between the two studies. Since
walking speed is known to inﬂuence the magnitude of lower-limb
muscle forces15, it is possible that differences in walking speed
between the current study [1.37 (1.30 to 1.44) m s1, Table I] and
that of Kim et al.22 [1.24 (SD 0.33) m s1] partially explain some of
the differences observed in the calculated values of muscle forces.
Furthermore, in the study by Kim and colleagues22, the patient hadGMAX GMED GMIN VASTI
Control group (n [ 18)
Age (yrs) r 0.195 0.96 0.84 106
P 0.439 0.705 0.739 0.676
Walking speed (m s1) r 0.593 0.076 0.047 0.727
P 0.009* 0.764 0.853 0.001*
PFJ OA group (n [ 60)
Age (yrs) r 0.86 0.138 0.125 0.174
P 0.514 0.295 0.340 0.185
KOOS-pain r 0.081 0.050 0.023 0.103
P 0.539 0.704 0.859 0.435
KOOS-symptoms r 0.026 0.029 0.041 0.069
P 0.843 0.826 0.754 0.598
KOOS-ADL r 0.045 0.053 0.062 0.133
P 0.734 0.685 0.637 0.311
KOOS-sport/rec r 0.018 0.050 0.056 0.261
P 0.892 0.702 0.669 0.097
KOOS-QoL r 0.059 0.036 0.029 0.111
P 0.652 0.784 0.824 0.396
Walking speed (m s1) r 0.145 0.090 0.040 0.495
P 0.267 0.494 0.763 <0.001*
Tibiofemoral (K/L)z rho 0.040 0.114 0.108 0.058
P 0.763 0.385 0.413 0.660
Lateral patellofemoral (K/L)y,z rho 0.084 0.104 0.060 0.072
P 0.524 0.430 0.649 0.586
Correlations using Pearson’s r correlation co-efﬁcient unless indicated.
*Denotes statistically signiﬁcant, P < 0.05.
VASTI ¼ vastus medialis, vastus lateralis and vastus intermedialis.
K/L Kellgren and Lawrence scale17: 0 ¼ no OA; 4 ¼ severe OA.
y K/L Kellgren and Lawrence scale adapted for PFJ18.
z Correlations using Spearman’s rho correlation co-efﬁcient.
Fig. 2. Muscle forces during the stance phase of walking. Mean (95% conﬁdence
interval) data are presented for the control [solid line (mean) with dark grey shading
95% CI; N ¼ 18] and PF JOA [dashed line (mean) with light grey shading 95% CI; N ¼ 60]
populations. Muscle symbols appearing in the graphs are: GMAX, GMED, GMIN and
VASTI (vastus lateralis, vastus medialis and vastus intermedius heads). IFS, IFO, CFS and
CFO signify ipsilateral foot-strike, ipsilateral foot-off, contralateral foot-strike and
contralateral foot-off, respectively.
Table IV
Between-group comparisons of normalised peak muscle forces between symp-
tomatic PFJ OA and control groups
Pain-free controly
N ¼ 18
Patellofemoral OAy
N ¼ 60
Mean differencey P
GMAX (BW) 0.69 [0.61 to 0.78] 0.70 [0.66 to 0.75] 0.01 [0.11 to 0.09] 0.796
GMED (BW) 1.41 [0.28 to 1.53] 1.26 [1.19 to 1.33] 0.15 [0.01 to 0.29] 0.041*
GMIN (BW) 0.24 [0.22 to 0.26] 0.21 [0.20 to 0.22] 0.03 [0.01 to 0.06] 0.013*
VASTI (BW) 1.26 [1.08 to 1.44] 1.16 [1.06 to 1.26] 0.10 [0.11 to 0.31] 0.355
*Denotes statistically signiﬁcant, P < 0.05.
y All values are mean [95% CI] and adjusted for walking speed.
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study contained individuals with no greater than K/L grade 2
radiographic OA. Thus, differences in peak VASTI force may be
partially accounted for by the disparity in the patient population. It
is difﬁcult to directly compare our data with that from a previous
study31, where lower-limb muscle forces were computed for
a cohort of younger individuals with PFJ pain syndrome, because an
EMG-driven modelling approach was used and all muscle force
data were normalised by the peak isometric force of each muscle.
Our ﬁnding of lower peak GMED and GMIN forces in those with
PFJ OA is consistent with emerging evidence that hip muscle
dysfunction is a dominant feature of individuals with PFJ pain
syndrome11. The GMED and GMIN primarily contribute to hip
abduction moments during walking32. Since the cross-sectional
nature of the study design precludes knowledge of the temporal
relationship between lower GMED and GMINmuscle forces and PFJ
OA development or progression, further studies are required to
conﬁrm the clinical implications of our ﬁndings. Our results indi-
cate that individuals with PFJ OA exhibit altered function that is
isolated to themore proximal segments, providing further evidence
for a potential link to PFJ pain syndrome.
We found no difference in peak VASTI and GMAX muscle force
in those with and without PFJ OA. Our results contrast with
previous studies that have measured peak isometric knee-extensor
torque using a dynamometer12,13; however, there is an imprecise
relationship between knee-extensor torque measured in an open-
kinetic-chain task and peak muscle force utilised during a func-
tional activity such as walking. Our results may reﬂect variability in
gait adaptations during walking in our population of people with
symptomatic PFJ OA. Notably, there was a non-signiﬁcant lower
peak VASTI muscle force (w8%) in our PFJ OA patients, which may
reﬂect that some individuals are likely to walk with lowered VASTI
force, potentially as a pain-relieving strategy. It is also possible that
deﬁcits in the coordination (e.g., onset timing) of the medial and
lateral components of the vasti may be more important than the
total peak VASTI force in individuals with PFJ OA, in a similar
manner to PFJ syndrome33. Future studies might evaluate VASTI
and GMAX muscle forces in functional tasks, such as stair ambu-
lation, which subject the PFJ to greater load, or evaluate the relative
coordination of the medial and lateral vasti.
Peak muscle forces were mostly not correlated with participant,
symptomatic or radiographic-speciﬁc characteristics, implying that
muscle forces alone do not reﬂect the severity of radiographic or
symptomatic disease. Although previous investigations of individ-
uals with predominantly tibiofemoral joint OA have observed
associations between radiographic OA severity and kinematics at
the hip34, these observations were only signiﬁcant for those with
severe radiographic OA (K/L grade 4). Similarly, many authors have
noted a difference in the knee adduction moment only in those
with more severe radiographic tibiofemoral disease35. It appears
likely that changes in gait mechanics at the knee may be associated
with the structural changes that accompany the OA disease process,
such as altered frontal plane alignment. Since our cohort wasrestricted to those with a K/L grade 2, it is not surprising that
radiographic disease severity was not associated with peak muscle
loading during gait. Although faster walking speed was associated
with a higher peak VASTI muscle force in the PFJ OA and control
groups and a higher peak GMAX muscle force in the control group,
walking speed was controlled for statistically and therefore the
between-group differences in muscle force noted in the current
study were not attributable to differences in walking speed.
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from net joint torques alone, simply because a given joint torque
can be satisﬁed by an inﬁnite combination of muscle forces.
Musculoskeletal modelling represented the only practicable
method for determining lower-limb muscle forces in the current
study. However, there are several limitations and assumptions
inherent in this modelling approach; for example, the physiological
properties prescribed for the muscle-tendon actuators included in
the model [e.g., peak isometric muscle force and the corresponding
muscle-ﬁbre length and tendon rest length; see Fig. 1(B)]. Impor-
tantly, the present study implemented scaled muscle-tendon
parameters for both the PFJ OA and control population (i.e.
parameters were scaled according to each participant's anthro-
pometry) and hence, any relative differences in muscle force
predictions are attributable mostly to differences in the experi-
mental gait data and not the parameters assumed in the model. We
also elected to analyse synergistic groups of muscles (i.e., GMAX,
GMED, GMIN, VASTI) and did not attempt to partition calculated
forces onto the various components of these muscle groups (e.g.,
vastus medialis vs intermedius vs lateralis within VASTI). Several
studies have shown that our approach of obtaining muscle force
estimates for synergistic groups of muscles is relatively insensitive
to changes in the values assumed for peak isometric muscle force
(or physiological cross-sectional area)36e38. Despite the afore-
mentioned limitations, the inverse-dynamics-based optimisation
approach employed in the current study is robust, computationally
efﬁcient, and has been used extensively to estimate lower-limb
muscle forces in walking15,39,40. Furthermore, indirect evidence is
available to support the validity of predicting lower-limb muscle
forces during walking using the approach taken in the present
paper22. Lastly, previous studies have shown temporal agreement
between predicted lower-limb muscle forces and recorded EMG41
and this relationship was also demonstrated in the present study
for a representative subject (Supplementary Fig. 1).
A ﬁnal limitation relates to the participant characteristics of
the control group. Although we attempted to recruit participants
who were matched on variables likely to inﬂuence muscle forces,
the control group was lighter and trending towards being
younger. We controlled for BW by normalising all muscle force
data, and age was not associated with the muscle force data. In
order to be included in the control group, participants had to
exhibit a K/L grade 1. While this is usually accepted as a crite-
rion for no OA, it is possible that participants in the control group
had some early/mild OA that may have affected their gait
pattern. It is also possible that some participants in either group
may have had coexisting hip OA. However, the control group
were required to have no knee pain and all participants were
required to report no hip/groin or lower-back symptoms. The
sample size for the control group was chosen to be as large as
could be practically achieved within the time and resource
constraints, and consequently the control group included much
fewer participants (N ¼ 18) than our PFJ OA cohort (N ¼ 60). This
difference reﬂected the difﬁculties in recruiting an older pop-
ulation from the general community with no knee or other
lower-limb complaints, who were physically active with no
radiographic knee OA, and who had the time and inclination to
attend for both radiographic and biomechanical evaluation.
Nevertheless, our sample size calculations revealed that we had
sufﬁcient power, despite the discrepant sample sizes.
This study is the ﬁrst to investigate the walking mechanics of
individuals with predominant PFJ OA. Our ﬁndings indicate that
individuals with PFJ OA ambulate with lower peak hip abductor
muscle force than their healthy counterparts. It is not known
whether a lower hip abductor muscle force contributes to, or is
a consequence of, the PFJ OA disease process.Author contributions
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